Wy. Liao et al., US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter, RADIOLOGY, 217(3), 2000, pp. 685-691
Citations number
36
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
PURPOSE: To evaluate the safety and accuracy of ultrasonography (US)-guided
transthoracic cutting biopsy for diagnosing peripheral thoracic lesions (<
3 cm).
MATERIALS AND METHODS: Fifty consecutive patients with peripheral thoracic
lesions less than 3 cm in diameter underwent US-guided percutaneous transth
oracic cutting biopsy with a modified technique. Fifty lesions (43 parenchy
mal lung, two pleural, two chest wall, and three anterior mediastinal lesio
ns) were sampled for biopsy. The final diagnosis was based on histopatholog
ic analysis of surgical specimens (n = 18) or clinical follow-up (n = 32).
RESULTS: The histology recovery rate was 98% (49 lesions), and the correct
diagnosis was obtained in 48 lesions (96%). Twenty-four (48%) lesions were
malignant and 26 (52%) were benign. The diagnostic accuracy for malignant l
esions was 92% (22 of 24 lesions). A specific benign diagnosis was made in
17 (65%) of the 26 benign lesions, and the negative predictive value for ma
lignancy was 93% (26 of 28 lesions). Only two patients (4%) developed postb
iopsy pneumothorax, and three (6%) developed postbiopsy hemoptysis. Biopsy
helped prevent surgery or thoracoscopy in 32 patients (64%): 18 patients wi
th benign disease and 14 with multiple metastases or inoperable cancer.
CONCLUSION: US-guided transthoracic cutting biopsy appears to be a safe and
effective method for diagnosing peripheral thoracic lesions less than 3 cm
in diameter. The high diagnostic accuracy for benign lesions and metastati
c lung cancer can help prevent surgery in many cases.